Air France to take a $193m hit as tourists shun Paris Olympics

Paris’ bid to host the 2024 Olympic Games is seen at the Arc de Triomphe in Paris on February 9, 2016. (Photo by LIONEL BONAVENTURE) AFP via Getty Images HThe specter of the 2024 Summer Olympics in Paris isn’t doing the French national airline’s bottom line any good. Air France announced on Monday that it … Read more

Nvidia’s secret sauce is starting to worry regulators

Nvidia has had a remarkable ride in its journey to become a $3 trillion heavyweight in the AI ​​industry. Now, authorities want to know if he got there fairly. French regulators are set to charge the Silicon Valley chip giant over concerns it has engaged in anti-competitive behavior, a Reuters report said, citing people familiar … Read more

The FDA is investigating a death that may be linked to mushroom-infused chocolates and meats

The Food and Drug Administration is investigating a death that may be linked to the Diamond Shruumz brand of mushroom-filled chocolates or treats. According to the agency, as of Monday, 48 illnesses and 27 hospitalizations were linked to the sweets. Prophet Premium Blends of Santa Ana, Calif., which makes the products, initiated a nationwide recall … Read more

FDA approves second Alzheimer’s drug that may slow onset of disease | Alzheimer’s

Federal health authorities gave approval Tuesday to an experimental new drug that has been shown to delay the onset of Alzheimer’s disease in trials. Donanemab, made by Eli Lilly, is the second drug to win Food and Drug Administration (FDA) approval to treat patients showing early symptoms of the disease, most notably cognitive impairment. Last … Read more

FDA approves Alzheimer’s drug donanemab after months of delay

The Food and Drug Administration gave approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits of modestly slowing the progression of the devastating disease outweigh its risks, drugmaker Eli Lilly announced. The agency, in a surprise move in March, had delayed approval of the drug to further review its safety and effectiveness. … Read more

Student loan borrowers owe $1.6 trillion. Almost half are not paying.

After an unprecedented three-year hiatus in federal student loan payments due to the pandemic, millions of borrowers began repaying their debt when billing resumed late last year. But not nearly as much. That reality, along with court rulings that regularly change the rules, have complicated the government’s efforts to restart its system for collecting the … Read more

Ford boss says Americans need to ‘fall back in love’ with smaller cars | The automotive industry

It’s time for the US to “fall back in love” with smaller cars, according to Ford’s chief executive. In a wide-ranging interview at the Aspen Festival of Ideas, Jim Farley said the auto industry should focus on smaller electric cars and commercial vehicles. He acknowledged that American consumers are “in love with these monster vehicles” … Read more

FTC sues to block $4 billion merger of mattress firms

See what clicks on FoxBusiness.com of Federal Trade Commission (FTC) announced Tuesday that it will file a lawsuit to block the proposed $4 billion merger between mattress maker Tempur Sealy and retailer Mattress Firm that was announced more than a year ago. The proposed agreement will be seen Tempur Sealy buys mattress firm and more … Read more

Levi’s, Apple and Coach are up to 80% off in Amazon’s epic Fourth of July sale

Updated at 02:56 PM EDT, July 2, 2024 LIVE: Amazon’s Best Fourth of July Deals Get your Fourth of July shopping started with these top Amazon sales. The Fourth of July is almost here; I don’t know about you, but I’m ready to soak up the sun, down some hotdogs and — most importantly — … Read more

Novo, Lilly Slide After Biden Calls for Cheaper Obesity Drugs

(Bloomberg) — Shares of Novo Nordisk A/S and Eli Lilly & Co. fell on Tuesday as US President Joe Biden continued his push for cheaper drugs by demanding price cuts for their blockbuster weight loss and diabetes drugs. Most Read by Bloomberg Companies are paying “unconscionably high prices” that are above those paid in other … Read more